Continuation and Maintenance Use of Antidepressants in Recurrent Depression
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Background: Maintenance antidepressant (AD) medication is the most commonly used preventive strategy in a highly recurrent disease, i.e. depression. Little is known about the discontinuation of maintenance AD use and the association with recurrence in daily clinical practice. The purpose was to examine the discontinuation rate of maintenance AD in daily clinical practice in recurrently depressed patients and the associated risk of recurrence. Methods: Prospectively AD maintenance medication and recurrence were examined in 172 euthymic patients with recurrent depression. AD user profiles before recurrence (nonusers, intermittent users, continuous users) were examined and related to recurrence over a 2-year follow-up period. Results: Less than half of the patients (42%) used AD continuously. Taking into account the minimal required adequate used dosage (≧20 mg fluoxetine equivalent), only 26% of the patients used AD as recommended by international guidelines. Despite continuous use of AD, 60.4% relapsed in 2 years. This relapse rate was comparable to the rate of the intermittent users (63.6%). In patients who stopped taking AD after remission and who received additional preventive CT, the recurrence rates were significantly lower than in non-AD-using patients treated with usual care (8 vs. 46%). Conclusions: The majority of recurrently depressed patients treated with AD discontinue maintenance AD therapy in daily primary and secondary clinical practice. AD seems to offer poor protection against relapse in this patient group. Patients who stopped using AD experienced less relapse, especially if they were treated with preventive CT. Alternative maintenance treatments (including preventive cognitive therapy after discontinuation of AD) should be studied in recurrently depressed patients with intermittent good remission, not only in secondary but also in primary care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, when comparing antidepressant maintenance treatment to tapering with psychological support, long-term relapse rates for depression are comparable34–36 or in some cases lower for patients receiving psychological therapy.37 38”
From Helping people discontinue long-term antidepressants: views of health professionals in UK primary care (2019) · cites this paper as [36]
In the citing paper
“On the other hand, possibly as a consequence of our optimisation of mADM in the control condition, the adherence rate with mADM seems to be rather high compared with some other studies (Bockting et al., 2008;Kuyken et al., 2008;Olfson et al., 2006).”
From Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial (2015) · cites this paper as Bockting et al., 2008
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
Morisky, D. E., Green, L. W., & Levine, D. M. (1986) · Medical Care · doi:10.1097/00005650-198601000-00007 · Cited by 5,317
SCL-90: an outpatient psychiatric rating scale--preliminary report.
Derogatis, L. R., Lipman, R. S., & Covi, L. (1973) · PubMed · Cited by 4,633
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.615 · Cited by 3,236
Ma, S. H., & Teasdale, J. D. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.1.31 · Cited by 1,390
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,297
Publication bias in meta-analysis its causes and consequences
Thornton, A. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00161-4 · Cited by 1,291
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997) · American Psychiatric Press eBooks · Cited by 983
Distributed Disturbances in Brain Structure and Function in Schizophrenia
(2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.1 · Cited by 969
Research works printed but not linked: 6
- 10.4088%2FJCP.v67n0508 · DOI · Paper page
- 10.1176%2Fappi.ajp.163.11.1905 · doi:10.1176/appi.ajp.163.11.1905 · Paper page
- 10.1159%2F000288931 · DOI · Paper page
- 10.4088%2FJCP.v66n0112 · DOI · Paper page
- 10.1176%2Fappi.ajp.161.10.1872 · DOI
- 10.1037%2F%2F0022-006X.68.4.615 · doi:10.1037//0022-006x.68.4.615 · Paper page
Cited by
Segal, Z. V., Bieling, P., Young, T., MacQueen, G., Cooke, R., Martin, L., Bloch, R., & Levitan, R. D. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.168 · Cited by 429
Increasing Psychological Well‐Being and Resilience by Psychotherapeutic Methods
Fava, G. A., & Tomba, E. (2009) · Journal of Personality · doi:10.1111/j.1467-6494.2009.00604.x · Cited by 362
“The return of depressive symptoms during maintenance antidepressant treatment is a common and vexing clinical phenomenon (Baldessarini, Ghaemi, & Viguera, 2002; Bockting et al., 2008; Papakostas, Perlis, Seifert, & Fava, 2007).”
BackgroundEfficacy and effectiveness of antidepressants: current status of research
Pigott, H. E., Leventhal, A. M., Alter, G. S., & Boren, J. J. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000318293 · Cited by 347
“both of which may significantly inflate the findings from meta-analyses that fail to control for these common forms of researcher bias. For now, prospective naturalistic studies are likely a better guide to estimate real-world outcomes. In STAR*D, even for the 1,085 remitted patients in step 1 who consented to continu…”
ResultGoldwater, D. S., Pavlides, C., Hunter, R. G., Bloss, E. B., Hof, P. R., McEwen, B. S., & Morrison, J. H. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.053 · Cited by 333
“Nevertheless, there is an almost 50% chance of mood disorder relapse following disease remission (Bockting et al., 2008, Kornstein, 2008).”
BackgroundBockting, C. L., Hollon, S. D., Jarrett, R. B., Kuyken, W., & Dobson, K. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.02.003 · Cited by 295
Self-citationAndrews, P. W., Bharwani, A., Lee, K. R., Fox, M., & Thomson, J. A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.018 · Cited by 281
“In nother study, the relapse rate over two years of continuous ADM reatment was 60% (Bockting et al., 2008).”
BackgroundDuarte, P. S., Miyazaki, M. C., Blay, S. L., & Sesso, R. (2009) · Kidney International · doi:10.1038/ki.2009.156 · Cited by 265
“Some reports have suggested that CBT is even superior to the use of antidepressive drugs(40,41) and that it can minimize the rates of discontinuation of antidepressive medication.(42) Finally, as many statistical comparisons were made, P values close to 0.”
ResultLong-term antidepressant use: patient perspectives of benefits and adverse effects
Cartwright, C., Gibson, K., Read, J., Cowan, O., & Dehar, T. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s110632 · Cited by 242
“Patients not treated with antidepressants after remission had the lowest recurrence rate (26%).(11) A recent investigation of patient-perceived side effects in the Netherlands found that 63% of patients reported, on average, 2.”
Sim, K., Lau, W. K., Sim, J., Sum, M. Y., & Baldessarini, R. J. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv076 · Cited by 218
More treatment but no less depression: The treatment-prevalence paradox
Ormel, J., Hollon, S. D., Kessler, R. C., Cuijpers, P., & Monroe, S. M. (2022) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102111 · Cited by 213
Penn, E., & Tracy, D. K. (2012) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312445469 · Cited by 200
“Poor compliance may be to blame: it is estimated that as few as 30% of patients take psychotropic medication as prescribed [Weich et al. 2007; Bockting et al. 2008] potentially due to the presence of adverse effects such as sexual dysfunctions in SSRIs coupled with an absence of noticeable…”
BackgroundSerfaty, M. A., Haworth, D., Blanchard, M., Buszewicz, M., Murad, S., & King, M. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.165 · Cited by 190
Biesheuvel-Leliefeld, K. E. M., Kok, G. D., Bockting, C. L. H., Cuijpers, P., Hollon, S. D., van Marwijk, H. W. J., & Smit, F. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.016 · Cited by 175
“…has not been studied well enough (Geddes et al., 2003; Kaymaz et al., 2008), there is divergent information about discontinuation of continuation- or maintenance ADM and the relation to relapse or recurrence (Bockting et al., 2008) and reported levels of non-adherence have been consistently high.”
BackgroundSelf-citationThe mechanisms of tolerance in antidepressant action
Fava, G. A., & Offidani, E. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.026 · Cited by 158
“The time to recurrencewasequivalent in subjects taking adequate versus inadequate dosages and in adherent and nonadherent patients (Bockting et al., 2008).”
InfluentialDoes Study Design Influence Outcome?
Rutherford, B. R., Sneed, J. R., & Roose, S. P. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000209348 · Cited by 158
“Among those who achieve remission of their depression on antidepressant medication, >60p will experience relapse of depression within 2 years despite continued medication use [”
BackgroundWakefield, J. C., & Schmitz, M. F. (2013) · World Psychiatry · doi:10.1002/wps.20015 · Cited by 133
“However, previous studies indicate that recurrence remains high in treated MDD samples and is not reduced to general population levels (25,27-29).”
BackgroundBockting, C. L. H., Klein, N. S., Elgersma, H. J., van Rijsbergen, G. D., Slofstra, C., Ormel, J., Buskens, E., Dekker, J., de Jong, P. J., Nolen, W. A., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30100-7 · Cited by 130
Self-citationPrimum Non Nocere: An Evolutionary Analysis of Whether Antidepressants Do More Harm than Good
Andrews, P. W., Thomson, J. A., Amstadter, A., & Neale, M. C. (2012) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00117 · Cited by 120
“In another study, 68% of patients who initially met remission criteria, and were exposed only to continuous antidepressant treatment, had a relapse over a 2 year period (Bockting et al., 2008).”
BackgroundGuidi, J., Fava, G. A., Fava, M., & Papakostas, G. I. (2011) · Psychological Medicine · doi:10.1017/s0033291710000826 · Cited by 118
“Of these, we excluded 11 studies that were duplicate publications or represented reanalyses of data published elsewhere (Fava et al. 1994, 1996, 1998c ; Paykel et al. 1999 ; Scott et al. 2000, 2003 ; Williams et al. 2000 ; Teasdale et al. 2002 ; Petersen et al. 2004 ; Bockting et al. 2005, 2008).”
BackgroundBockting, C. L. H., Spinhoven, P., Wouters, L. F., Koeter, M. W. J., Schene, A. H., & DELTA Study Group (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04784blu · Cited by 113
Self-citationZetsche, U., & Joormann, J. (2010) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2010.06.001 · Cited by 120
Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression
Lok, A., Mocking, R. J. T., Ruhé, H. G., Visser, I., Koeter, M. W. J., Assies, J., Bockting, C. L. H., Olff, M., & Schene, A. H. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.10.005 · Cited by 99
“The non-continuous group both included patients who took antidepressants intermittently and patients that did not take antidepressants at all (Bockting et al., 2008).”
Self-citationWilkinson, S. T., Holtzheimer, P. E., Gao, S., Kirwin, D. S., & Price, R. B. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.09.004 · Cited by 95
“Pharmacological/somatic therapies are challenging to maintain in the long term owing to patient discontinuation (11) and the rarity of follow-up opportunities in community practice (12).”
Van Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90
Adherence to continuation and maintenance antidepressant use in recurrent depression
ten Doesschate, M. C., Bockting, C. L. H., & Schene, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.07.011 · Cited by 86
Self-citationRisk factors for non-adherence to antidepressant treatment in patients with mood disorders
Cuevas, C. D. L., Peñate, W., & Sanz, E. J. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1582-9 · Cited by 111
Price, R. B., Spotts, C., Panny, B., Griffo, A., Degutis, M., Cruz, N., Bell, E., Do-Nguyen, K., Wallace, M. L., Mathew, S. J., et al. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220216 · Cited by 85
Prodromal stage of major depression
Fava, G. A., & Tossani, E. (2007) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2007.00005.x · Cited by 81
Fornaro, M., Anastasia, A., Novello, S., Fusco, A., Pariano, R., De Berardis, D., Solmi, M., Veronese, N., Stubbs, B., Vieta, E., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.025 · Cited by 80
New Modalities of Assessment and Treatment Planning in Depression: The Sequential Approach
Fava, G. A., & Tomba, E. (2010) · CNS Drugs · doi:10.2165/11531580-000000000-00000 · Cited by 80
Hengartner, M. P. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320921694 · Cited by 72
A systematic review of long-term studies of drug treated and non-drug treated depression
Hughes, S., & Cohen, D. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.027 · Cited by 71
Changes in CREB Phosphorylation and BDNF Plasma Levels during Psychotherapy of Depression
Koch, J. M., Hinze-Selch, D., Stingele, K., Huchzermeier, C., Göder, R., Seeck-Hirschner, M., & Aldenhoff, J. B. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000209350 · Cited by 67
Can a One-Item Mood Scale Do the Trick? Predicting Relapse over 5.5-Years in Recurrent Depression
van Rijsbergen, G. D., Bockting, C. L. H., Berking, M., Koeter, M. W. J., & Schene, A. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046796 · Cited by 60
“Patients were asked about their use of ADM for the last depression before entry of the study and whether they continued using ADM after remission [36,37].”
MethodSelf-citationHuijbers, M. J., Spinhoven, P., Spijker, J., Ruhé, H. G., van Schaik, D. J. F., van Oppen, P., Nolen, W. A., Ormel, J., Kuyken, W., van der Wilt, G. J., et al. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.115.168971 · Cited by 58
“Mindfulness-based cognitive therapy (MBCT) and maintenance antidepressant medication (mADM) both reduce the risk of relapse in recurrent depression, but their combination has not been studied.”
Self-citationDisruption of Neural Homeostasis as a Model of Relapse and Recurrence in Late-Life Depression
Andreescu, C., Ajilore, O., Aizenstein, H. J., Albert, K., Butters, M. A., Landman, B. A., Karim, H. T., Krafty, R., & Taylor, W. D. (2019) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.07.016 · Cited by 56
Huijbers, M. J., Spijker, J., Donders, A. R. T., van Schaik, D. J., van Oppen, P., Ruhé, H. G., Blom, M. B. J., Nolen, W. A., Ormel, J., van der Wilt, G. J., et al. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-125 · Cited by 53
“First, many patients are unwilling to continue mADM for a longer period [6] and adherence is typically low [7].”
Self-citationHengartner, M. P. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00275 · Cited by 52
“In an observational study of patients with remitted recurrent depression, maintenance therapy related to a higher recurrence rate than discontinuation (70).”
BackgroundTerapia cognitivo-comportamental da depressão
Powell, V. B., Abreu, N., Oliveira, I. R. D., & Sudak, D. (2008) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462008000600004 · Cited by 45
Bockting, C., Smid, N. H., Koeter, M. W. J., Spinhoven, P., Beck, A. T., & Schene, A. H. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.048 · Cited by 56
“During the first 2 years (Bockting et al., 2008), information on AD use (type and dosage) and other psychological treatment (number of counseling or psychotherapy sessions) was collected every 3 months with the Trimbos/IMTA Self Report Questionnaire for Costs Associated with Psychiatric Illness (TIC-P (Hakkaart-van Ro…”
Self-citationHolma, I. A. K., Holma, K. M., Melartin, T. K., & Isometsä, E. T. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.022 · Cited by 56
Huijbers, M. J., Spinhoven, P., Spijker, J., Ruhé, H. G., van Schaik, D. J. F., van Oppen, P., Nolen, W. A., Ormel, J., Kuyken, W., van der Wilt, G. J., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.023 · Cited by 43
“On the other hand, possibly as a consequence of our optimisation of mADM in the control condition, the adherence rate with mADM seems to be rather high compared with some other studies (Bockting et al., 2008; Kuyken et al., 2008; Olfson et al., 2006).”
ResultSelf-citationWie viele Geschlechter gibt es und kann man sie wechseln?
Ponseti, J., & Stirn, A. V. (2019) · Zeitschrift für Sexualforschung · doi:10.1055/a-0978-7137 · Cited by 43
“…auf eine Art Begleitbehandlung eingeschränkt, deren Aufgabe darin besteht, Patient/innen bei der Findung ihrer Geschlechtsidentität zu unterstützen und etwaige begleitende Probleme, die im Zusammenhang mit Geschlechtsinkongruenz auftreten, zu mildern (Bockting et al. 2008; Hidalgo et al. 2013).”
BackgroundBrandes, V., Terris, D. D., Fischer, C., Loerbroks, A., Jarczok, M. N., Ottowitz, G., Titscher, G., Fischer, J. E., & Thayer, J. F. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000319529 · Cited by 49
“Poor adherence to recommended treatment is a further issue complicating the management of depression and prevention of recurrent episodes [”
BackgroundHengartner, M. P., Angst, J., & Rössler, W. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000488802 · Cited by 42
Zhang, Y., Anoopkumar‐Dukie, S., Mallik, S. B., & Davey, A. K. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02331-1 · Cited by 40
“Current antidepressant medications aim to increase levels of monoamine neurotransmitters (Penn and Tracy, 2012), but these antidepressants may have multiple side effects and toxicities which can result in poor compliance (Bockting et al. 2008; Penn and Tracy 2012).”
BackgroundShen, J., Hossain, N. K., Streiner, D. L., Ravindran, A. V., Wang, X., Deb, P., Huang, X., Sun, F. F., & Shapiro, C. M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.04.047 · Cited by 36
“The effects may be detected only short-term, as benefits from antidepressants may be not sustained, as demonstrated by Bockting et al. (2008).”
STAR*D: A Tale and Trail of Bias
Pigott, H. E. (2011) · Ethical Human Psychology and Psychiatry · doi:10.1891/1559-4343.13.1.6 · Cited by 31
Bowers, H. M., Williams, S. J., Geraghty, A. W. A., Maund, E., O’brien, W., Leydon, G., May, C. R., & Kendrick, T. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027837 · Cited by 31
Mocking, R. J. T., Figueroa, C. A., Rive, M. M., Geugies, H., Servaas, M. N., Assies, J., Koeter, M. W. J., Vaz, F. M., Wichers, M., van Straalen, J. P., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009510 · Cited by 31
Self-citationAbdulah, D. M., Alhakem, S. S. M., & Piro, R. S. (2018) · Nordic Journal of Music Therapy · doi:10.1080/08098131.2018.1546222 · Cited by 32
“Poor adherence toward target intervention is an issue in intervention studies (Bockting et al., 2008; Mascha, Bockting, & Schene, 2009).”
BackgroundWolff, J., Reißner, P., Hefner, G., Normann, C., Kaier, K., Binder, H., Hiemke, C., Toto, S., Domschke, K., Marschollek, M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255192 · Cited by 40
“In addition to less severe symptoms, there are other potential reasons for a hospital treatment without antidepressants, such as patients’ refusal to take the medication [49].”
BackgroundThe 6-month persistence on SSRIs and associated economic burden
Ereshefsky, L., Saragoussi, D., Despiégel, N., Hansen, K., François, C., & Maman, K. (2010) · Journal of Medical Economics · doi:10.3111/13696998.2010.511050 · Cited by 35
Biesheuvel-Leliefeld, K. E. M., Dijkstra-Kersten, S. M. A., van Schaik, D. J. F., van Marwijk, H. W. J., Smit, F., van der Horst, H. E., & Bockting, C. L. H. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000472260 · Cited by 29
Self-citationBockting, C. L., Elgersma, H. J., van Rijsbergen, G. D., de Jonge, P., Ormel, J., Buskens, E., Stant, A. D., de Jong, P. J., Peeters, F. P., Huibers, M. J., et al. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-8 · Cited by 29
“In line with other studies on this preventive CT, CT was effective [ 6 ] and cost-effective [Bockting CLH, Dijkgraaf MGW, Hakaart-van Roijen L et al. Costeffectiveness of relapse-prevention cognitive therapy in recurrent depression: a two year study.”
BackgroundMethodResultInfluentialSelf-citation‘Never change a winning team’: GPs’ perspectives on discontinuation of long-term antidepressants
Leeuwen, E. V., Anthierens, S., van Driel, M., Sutter, A. D., van den Branden, E., & Christiaens, T. (2021) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2021.2006487 · Cited by 30
de Jonge, M., Bockting, C., Kikkert, M., van Dijk, M. K., van Schaik, A., Peen, J., Hollon, S. D., & Dekker, J. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000395 · Cited by 30
Self-citationIdentifying Risk for Attrition during Treatment for Depression
Warden, D., Trivedi, M. H., Wisniewski, S. R., Lesser, I. M., Mitchell, J. R., Balasubramani, G. K., Fava, M., Shores‐Wilson, K., Stegman, D., & Rush, A. J. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000235977 · Cited by 33
Cosci, F., Mansueto, G., & Fava, G. A. (2020) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2020.1779308 · Cited by 29
Failure to Respond after Reinstatement of Antidepressant Medication: A Systematic Review
Bosman, R. C., Waumans, R. C., Jacobs, G. E., Oude Voshaar, R. C., Muntingh, A. D. T., Batelaan, N. M., & van Balkom, A. J. L. M. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491550 · Cited by 21
“Firstly, during continuous treatment with an antidepressant the effect of the antidepressant may decrease [3– 7].”
BackgroundVittengl, J. R., Clark, L. A., Thase, M. E., & Jarrett, R. B. (2015) · Psychotherapy · doi:10.1037/pst0000021 · Cited by 22
“…low positive activation (e.g., reduced energy, enthusiasm, gregariousness; Vittengl et al., 2010); (d) discontinuing antidepressant medication (Bockting et al., 2008); (e) with fewer stressful life events (Bockting et al., 2006); and (f) with a greater history of childhood trauma (Williams et…”
BackgroundCombined Treatment of Depression
Busch, F. N., & Sandberg, L. S. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.10.002 · Cited by 19
Hengartner, M. P., Passalacqua, S., Andreae, A., Heinsius, T., Hepp, U., Rössler, W., & von Wyl, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00079 · Cited by 20
“In accordance with mounting evidence from observational studies, our findings even raise the possibility that antidepressant pharmacotherapy may increase relapse rates and impair recovery in the long run (20, 21, 23, 24, 26).”
ResultSensitivity to Change and Predictive Validity of the MOODS-SR Questionnaire, Last-Month Version
Miniati, M., Rucci, P., Frank, E., Oppo, A., Kupfer, D. J., Fagiolini, A. M., & Cassano, G. B. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000201937 · Cited by 19
Biesheuvel-Leliefeld, K. E. M., Dijkstra‐Kersten, S. M. A., van der Horst, H. E., van Schaik, A., Bockting, C., Bosmans, J. E., Smit, F., & van Marwijk, H. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-59 · Cited by 18
“Also, adherence in AD users is estimated at only 50 % at best [11-13].”
BackgroundSelf-citationPositive Psychotherapy and Social Change
Fave, A. D., & Fava, G. A. (2010) · Springer eBooks · doi:10.1007/978-90-481-9938-9_15 · Cited by 17
Huijbers, M. J., Spinhoven, P., van Schaik, A., Nolen, W. A., & Speckens, A. E. M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.01.041 · Cited by 20
“2008), adherence to mADM is generally low (Bockting et al., 2008)”
BackgroundSelf-citationSlofstra, C., Klein, N. S., Nauta, M. H., Wichers, M., Batalas, N., & Bockting, C. (2017) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2017.07.003 · Cited by 12
Self-citationMcPherson, S., & Hengartner, M. P. (2019) · BJPsych Open · doi:10.1192/bjo.2019.65 · Cited by 15
de Jonge, M., Bockting, C., Kikkert, M., Bosmans, J. E., & Dekker, J. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0508-8 · Cited by 11
“However, 70–80 % of patients are not willing to take AD for a long period of time [14, 15].”
BackgroundSelf-citationThe possible place for psychedelics in pharmacotherapy of mental disorders
Wojtas, A. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00550-9 · Cited by 14
“Combined with numerous adverse effects, this leads to poor compliance, with possible levels as low as 30% of the patients [36].”
BackgroundMondin, T. C., Cardoso, T. D. A., Jansen, K., da Silva, G. D. G., Souza, L. D. D. M., & da Silva, R. A. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.014 · Cited by 12
Vittengl, J. R., & Jarrett, R. B. (2013) · Wiley eBooks · doi:10.1002/9781118528563.wbcbt48 · Cited by 13
Seifert, J., Maier, H. B., Führmann, F., Bleich, S., Stübner, S., Sieberer, M. G., Bernegger, X., Greil, W., Schüle, C., Toto, S., et al. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02504-6 · Cited by 16
“In general, the use of higher doses of any ADD may be offset by a lower tolerability due to ADRs (Jakubovski et al.”
BackgroundInfluentialDelayed Loss of Efficacy and Depressogenic Action of Antidepressants
Raja, M. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181c0e60b · Cited by 10
White matter hyperintensities and relapse risk in late-life depression
Pearcy, L. B., Karim, H. T., Butters, M. A., Krafty, R. T., Boyd, B. D., Banihashemi, L., Szymkowicz, S. M., Landman, B. A., Ajilore, O., Taylor, W. D., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.04.116 · Cited by 8
“…et al., 2018; Judd et al., 1998; Nierenberg et al., 2010; Nierenberg et al., 2003), residual anxiety and sleep disturbance (Andreescu et al., 2007; Deng et al., 2018; Reynolds III et al., 2006), and non-adherence with antidepressant treatment (Bockting et al., 2007; ten Doesschate et al., 2009).”
Personalized psychiatry with human iPSCs and neuronal reprogramming
Bardy, C., Greenberg, Z., Perry, S. W., & Licinio, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813176-3.00012-2 · Cited by 10
Recognizing depression in late life
Edlund, B. J., Lauerer, J., & Drayton, S. J. (2015) · The Nurse Practitioner · doi:10.1097/01.npr.0000459729.92650.ce · Cited by 9
Differing antidepressant maintenance methodologies
Safer, D. J. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.07.021 · Cited by 9
Huijbers, M. J., Wentink, C., Lucassen, P. L., Kramers, C., Akkermans, R., Spijker, J., & Speckens, A. E. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290965 · Cited by 7
“Not surprisingly, many patients are unwilling to continue ADM extendedly [11] and prefer psychological treatment [12].”
Self-citationDepressive feelings, feelings of unhappiness, and subsequent psychological wellbeing among workers
Kawada, T., Kuratomi, Y., & Kanai, T. (2011) · Work · doi:10.3233/wor-2011-1179 · Cited by 6
Peñaranda, A. P. B., Valencia, J. G., Guarín, M. R., Borrero, Á. E. A., Castro, S., Bradford, A. M. D. L. H., Riveros, P. M., Jaramillo, L. E., Brito, E., Acosta, C. A. P., et al. (2012) · Revista Colombiana de Psiquiatría · doi:10.1016/s0034-7450(14)60045-7 · Cited by 9
The association between antidepressant use and depression eight years later: A national cohort study
Colman, I., Zeng, Y., Ataullahjan, A., Senthilselvan, A., & Patten, S. B. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.02.001 · Cited by 6
“In particular, cognitive behavioral therapy has been shown to prevent relapse of depressive symptoms over several years after the initial episode (Bockting et al., 2009; Fava et al., 2004), by changing the way individuals who have had a depressive episode process depression-related material from an…”
BackgroundBreaking the Rhythm of Depression: Cognitive Behavior Therapy and Relapse Prevention for Depression
Bockting, C. (2010) · Pure Amsterdam UMC · Cited by 5
Self-citationWakefield, J. C., Lorenzo‐Luaces, L., & Lee, J. J.-H. (2017) · Evolutionary psychology · doi:10.1007/978-3-319-60576-0_2 · Cited by 12
Psicoterapias comportamentais no tratamento da depressão
Cardoso, L. R. D. (2017) · Psicologia Argumento · doi:10.7213/psicolargum.v29i67.20359 · Cited by 19
Late life depression: Challenge or curse for the general practitioner (GP). A cohort study
Stojanović-Špehar, S., Ozretić, L., Blažeković-Milaković, S., & Bergman-Marković, B. (2010) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2010.09.008 · Cited by 4
“Other recent studies suggest that more than half of the recurrently depressed patients discontinue maintenance therapy in daily primary practice (Bockting et al., 2008) with non-adherence to treatment continuation ranging from 39.”
BackgroundGómez–Restrepo, C., Peñaranda, A. P. B., Valencia, J. G., Guarín, M. R., Narváez, E. B., Jaramillo, L. E., Acosta, C. A. P., Pedraza, R. S., & Castro, S. (2012) · Revista Colombiana de Psiquiatría · doi:10.1016/s0034-7450(14)60044-5 · Cited by 6
Ivanets, N. N., Kinkulkina, M. A., Tikhonova, Y. G., Izumina, T. A., & Lazareva, A. V. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202012011133 · Cited by 5
Lohse, M. J., & Müller-Oerlinghausen, B. (2008) · Springer eBooks · doi:10.1007/978-3-540-69219-5_39 · Cited by 6
Remission is insufficient: predictors and mechanistic models of recurrence in late-life depression
Taylor, W. D., Gerlach, A., Szymkowicz, S. M., Gujral, S., & Andreescu, C. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02324-2 · Cited by 4
The Controversy Over Antidepressant Drugs in an Era of Evidence-Based Practice
Littrell, J. L., & Lacasse, J. R. (2012) · Social Work in Mental Health · doi:10.1080/15332985.2012.699444 · Cited by 4
“A study by Bockting et al. (2008) found that the continuous users did not differ from the”
BackgroundPsychopharmacology Is Not Evidence-Based Medicine
Gøtzsche, P. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-44911-1_2 · Cited by 6
Effectiveness of mental therapy for poor medication adherence in depression: A review
Xu, S., Liu, B., & Zhang, Y. (2020) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v19i8.30 · Cited by 3
Vittengl, J. R., Jarrett, R. B., Ro, E., & Clark, L. A. (2024) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-230016 · Cited by 3
“Even in these cases, however, planning for tapering and stopping ADM within weeks to months (e.g., by switching to cognitive-behavioral therapy or Well-Being Therapy) appears wise to reduce relapse risk, side-effect burden, and discontinuation syndrome [13,69,70].”
Psicoterapias comportamentais no tratamento da depressão
Cardoso, L. R. D. (2017) · Psicologia Argumento · doi:10.7213/rpa.v29i67.20359 · Cited by 11
Abu-Ashour, W., Delaney, S., Farrell, A., Gamble, J., Hawboldt, J., & Sale, J. E. M. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251322401 · Cited by 5
Chen, Y., Markowitz, J. C., Blanco, C., Hershman, D. L., Zhang, J. T., & Hellerstein, D. J. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07250-9 · Cited by 2
Cognitive-Behavioral Therapy for Depression
Abreu, N., Powell, V. B., & Sudak, D. M. (2012) · InTech eBooks · doi:10.5772/30200 · Cited by 2
“Many recent reviews describe substantial decrement in response to antidepressant medication even if the patient continues taking the medication properly, an event that occurs only 26% of the time (Bockting et al., 2008).”
Lok, A., Visscher, T. L. S., Koeter, M. W. J., Assies, J., Bockting, C., Verschuren, W. M. M., Gill, A., & Schene, A. H. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000320898 · Cited by 2
“although a substantial part (20–60p) of the recurrently depressed patients use ADs for lengthy periods of time [”
BackgroundSelf-citation
Metadata
- Authors
- Bockting, C. L. H., ten Doesschate, M. C., Spijker, J., Spinhoven, P., Koeter, M. W. J., & Schene, A. H.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Leiden University (NL)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2007-12-14
- Volume
- 77
- Issue
- 1
- Pages
- 17-26
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2012949854
- Cited by
- 121
- References
- 53
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 4 · 2019: 7 · 2018: 7 · 2017: 8 · 2016: 4 · 2015: 10 · 2014: 3 · 2013: 4 · 2012: 9
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- recurrent depression, antidepressant discontinuation, relapse prevention, relapse risk, cognitive therapy, primary care, secondary care
- MeSH terms
- Adult, Antidepressive Agents, Combined Modality Therapy, Depressive Disorder, Major, Major Depressive Disorder, Drug Administration Schedule, Female, Follow-Up Studies, Humans, Long-Term Care, Male, Middle Aged, Patient Compliance, Patient Dropouts, Personality Disorders, Prospective Studies, Cohort Studies, Comorbidity, Cognitive Behavioral Therapy, Treatment Outcome, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.